By the way, I feel for all those who are losing their jobs at TRXC, it's got to hurt. The sad thing is that the ones who deserve to lose their jobs (executives) will likely get a bonus this year.
Sentiment: Strong Sell
TRXC CEO is dillusional. And this was one disasterous quarter.
SurgiBot an utter failure. They've abanoned trying to get it apporved in the U.S. They aren't even going to try for European approval, I wonder why? Analysts seriously unhappy on the conf call. They blew $100Million buying the already European approved ALF-X system last year AND HAVEN'T SOLD A SINGLE SYSTEM (and CEO would not commit to even selling a single ALF-X system in 2016). You think SOFAR knew something when they dumped ALF-X?
The sharks at Intuitive have taken every single surgical robot sale, EVERY ONE! ISRG will do WHATEVER IT TAKES to put these guys out of business. It's just business. If these guys had half a brain, they'd give away a half dozen systems for a $500K price tag JUST TO SAY THEY SOLD SOME and get some real world experience.
The cherry on top of this whole ice cream sundae of a joke is that they were savvy enough to dupe $75 million out of starry eyed small investors to continue the charrade for another year or so. $75MM may keep them afloat for a while but it CERTAINLY won't get them to profitability!
Surgibot and ALF-X may some day make some money, but it won't be current shareholders who profit from it.
Sentiment: Strong Sell
From the P.R.
The Company has evaluated the operational and financial feasibility of pursuing 510(k)s for SurgiBot and ALF-X concurrently, and has decided to reprioritize its near-term regulatory efforts and focus on the ALF-X 510(k) submission.
What makes them think ALF-X will do any better?
Sentiment: Strong Sell
All the anticipation about soooooo many companies wanting to partner on Afrezza, but NOPE.....
Mannkind will be hiring ex-fuller brush salesment to go door to door in hope of hocking a few doses!
What a bust!
If you price a stock far enough in the hole, you'll eventually find a few sharks (flipper) who will roll the dice in hopes of grabbing a quick couple percent profit.
This thing will be below a buck within a few weeks when the sharks are gone.
Sentiment: Strong Sell
UNXL actually canned their own touchscreen technology and bought a different technology from Atmel back in April 2015 for a nominal sum. I wonder why Atmel sold it??
They've had about a dozen SMALL design wins in some niche products, Still no revenue. Revenue won't start until late this year and value of contracts is averaging only about $1million each.
Company is bleeding cash and there is no end in sight. Everybody was thinking theses were big money design wins and the cash would be rolling in. Management had to bring penny stock investors back to reality on the conf call last night.
The company will likely survive for a while, the question is how much cash will it bleed and how much will shareholders be dilluted along the way. You can't live on sub million dollar revenue. And you can't survive on piddly contracts that are only worth a million bucks that take nine months to get underway and where the million bucks is spread over three years.
Reminds me of LQMT, Liquidmetal. Great product, just cant sell enough of it to cover all the executives salaries. Company just keeps limping along, doing stock hype press releases and subsequent secondary stock offering again and again........
Exactly. cash is gone by end of the year. You have to think like a CFO, you raise cash when you can, you don't wait until you are broke.
Nobody offers money to anyone who is broke without sticking it to them, if they'll give them money at all.
No, actually I'm thinking like a smart CFO. You raise money when you can. This company is on the hairy edge of making it. Better to dillute now when stock price is up 5X and dorm room traders have run it up than when nobody wants the stock and you have to give it away like last time.
Remember what happened last time they did a stock secondary in Nov 2015? Stock closed @ $1.45, the offered stock with warrants at $0.85! Stock went sub $60 after that.
No revenue for next 6-9 months, burning $4 million per qtr and that will go up as they start to ramp production.
All 15 orders only equals about $1.5 million revenue per quarter.
Do the math...............
UNXL has an outstanding shelf registration. They can issue stock at any time. Listen to the conf call. CFO kind of mumbled it at the end of the list of financing options.
You need to think like a CFO, you raise money when you can, NOT when you need it. And you raise it by the cheapest means necessary.
UNXL going to be burning big cash for next 12-18 months.
Stock up 500%. If I were a CFO, I'd be filling my coffers real soon by selling shares.
Again seasonedinvestor79 seems to think these orders are going to all pour in Sept. seasonedinvestor79 should really listen to conf calls. That is when order deliveries begin. As CEO warned on the call this amount is for 18 months to THREE YEARS, that works out to about $1.25 million in sales per quarter, ROFLMAO!
As small deliveries begin in Sept, customers will test the product and IF it can meet quality requirements they will ramp up to full deliveries over a few months. then some money will trickle in.
seasonedinvestor79 needs to learn to read a balance sheet. Only $4.8MM cash on bal sheet as of March.
Per CFO's very clear statement on the conf call they are burning $4million+ per quarter from operations. Evidently seasonedinvestor79 doesn't listen to conerence calls or didn't have his hearing aid turned upl
Looks like doouucchee bag Spence is stuffing the ad pages by having 200 new cold calling sales people selling uses display ads that don't work.
But hey, he got a pop in the stock price.
No doubt, after jaaakkking each other off, Jim Cramer will have him on the show to do an encore for Jim's viewers!
Well stroked Spence, well stroked.
Business is still in decline, debt is huge, still losing tons of money. Book value means little if they can't service the debt.
Future is very dependant on housing market. Then you have to throw in all the legal issues regarding past practices and ability (or lack of) to do business in key states.
Bottom line, the future is so extremely unpredictable that whomever has the loudest megaphone will move the stock in the near term.
Why is DMD community defending this company. SRPT deliberately avoided going through the FDA PhIII process.
SRPT could have easily followed two parallel paths:
1) They could have pursued approval on the 12 patient data and if over time it became unequivical the drug would be days away from approval. Unfortunately the data is NOT unequivocal.
2) They could have simultaneously pursued the PhIII trial which would be three years along by now, but they simply chose to roll the dice and delay, delay, delay...
The sufferers of DMD have my great sympathys, but from where I stand I would be seriously pizzzed at this company for avoiding the PhIII trial for so many years.
Let's see.... if SRPT didn't stall for THREE FREEKING YEARS, trying to avoid going through the rigorous PhIII trial process, right now we'd be three years closer to knowing if it actually works.
Why is the DMD community not OUTRAGED at SRPT? They tried to scam the system and the FDA called them out!
So the FDA did a good job of crafting question 7 to prevent subjecting AdComm members to a bunch of emotions from desperate DMD sufferers & their families who would apporve drinking gasoline to treat DMD if SRPT told them that would help!
Took a lot of courage on the part of FDA to stand up to a tidal wave of emotion fomented by the greedy money mongers at SRPT.
Do the ffffoooooccckkkinggg trials SPRT!
SRPT cheerleader Adam Fartstain currently paased out in a pile of his own puke after his stockloveer SRPT gets shot down due to shoddy science.
Ya see, Adam is a PolySci major. Science to Adam is just an abstract concept to be delt with through bullying!
Why, why, why did they put off for sooooo long, doing well designed PhII trial?
Yes some participants would recieve sham therapy, but it's the only way to prove whether it works..
What's the alternative? We fill every FDA AdComm with 100's of screaming patients (who in the future will be paid by the drug company) telling them to ignore science and approve a drug that may or may not work and charge the government $100K per year for it????? And where does that take us????